British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

C the Signs United Kingdom England

is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer. Co-hosted by the Digital Medicine Society (DiMe) and Moffitt Cancer Center, alongside the Office of the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH), it convenes the many diverse stakeholders needed to unleash the power of innovation to create a future that's free of cancer burden. To learn more or participate in CancerX's pre-competitive, evidence-generating efforts; Accelerator cohort; or demonstration projects, visit www.cancerx.health. 

ABOUT THE CANCERX ACCELERATOR:
The CancerX Accelerator program aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations. Startup participants benefit from valuable mentorship, comprehensive training and direct access to key players in the health care industry, including providers, payers and pharmaceutical companies. This collaborative environment enables startups to develop, test and implement their cancer focused innovation on a larger scale.
https://cancerx.health/accelerator/

ABOUT THE 16 START-UPS:
A team of Accelerator Champions and judges from the CancerX community led three rounds of judging earlier this year to select this impressive cohort group. The full list of startups includes: The Blue Box, C the Signs, Cancer Insights, Curvia, EnteroTrack, Gesund.ai, Gray Oncology, LindAI, Mika Health, Navya, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, and Xanthos.

ABOUT THE PROGRAMME:

As a member of the CancerX accelerator, start-ups will now participate in a rich, 4-month program where they will:

Engage with members of the healthcare ecosystem to test and validate their solutions.Get expert guidance from CancerX Mentors.Graduate with a roadmap to successfully scale our company, an opportunity to move forward with our sponsor, and a community that will continue to support our development.

FURTHER INFORMATION:

-  For further information on The White House Cancer Moonshot Announcement
https://www.whitehouse.gov/briefing-room/statements-releases/2022/02/02/fact-sheet-president-biden-reignites-cancer-moonshot-to-end-cancer-as-we-know-it/#:~:text=Based%20on%20the%20progress%20made%20and%20the%20possibility,and%20their%20families%20living%20with%20and%20surviving%20cancer.
-  For further questions or queries on CancerX: [e-mail]
-  For the CancerX logo (Horizontal + Vertical)
-  For further information on C the Signs: www.cthesigns.com
-  For further information for press or media queries please contact: Charlotte Beams, Communications Officer, [e-mail]

ABOUT HEALTHCARE UK:

Healthcare UK is a joint initiative of the Department of Health and Social Care, NHS England and the Department for Business and Trade. Healthcare UK promotes the British healthcare sector internationally to drive export opportunities and works with the NHS to strengthen its capacity to operate and succeed internationally.

View original content:https://www.prnewswire.co.uk/news-releases/british-technology-company-c-the-signs-selected-by-the-white-house-backed-accelerator-programme-cancerx-to-half-cancer-deaths-302072308.html

@ prnewswire.co.uk